buspirone has been researched along with Dyslipidemia in 1 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raghunathan, S | 1 |
| Tank, P | 1 |
| Bhadada, S | 1 |
| Patel, B | 1 |
1 other study available for buspirone and Dyslipidemia
| Article | Year |
|---|---|
Evaluation of buspirone on streptozotocin induced type 1 diabetes and its associated complications.
Topics: Animals; Blood Glucose; Buspirone; C-Reactive Protein; Cardiovascular Diseases; Diabetes Mellitus, E | 2014 |